Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jessica Kaylor

Physician Assistant Pittsburgh, PA Physician Assistant

NPI 1760777858 CMS profile 11053416

5770 Baum Blvd, Pittsburgh, PA 15206

Open in the dashboard

General payments

$7,734

308 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jessica Kaylor of Pittsburgh, PA is reported in the CMS Open Payments database as having received $7,734 across 308 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,542 75
2024 General $3,054 129
2023 General $2,086 92
2022 General $839 6
2021 General $212 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jessica Kaylor
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Jessica Kaylor were reported at $1,542. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Jessica Kaylor Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $212 $132 $37–$438 $132
2022 $839 $155 $48–$522 $149
2023 $2,086 $167 $52–$557 $160
2024 $3,054 $178 $55–$600 $164
2025 $1,542 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Pfizer Inc. $1,177 19 payments
  2. AbbVie, Inc. $1,062 39 payments
  3. E.R. Squibb & Sons, L.L.C. $830 37 payments
  4. Sun Pharmaceutical Industries Inc. $570 24 payments
  5. UCB, Inc. $503 35 payments
  6. Journey Medical Corporation $421 13 payments
  7. Lilly USA, LLC $377 12 payments
  8. Dermavant Sciences, Inc. $374 12 payments
  9. Galderma Laboratories, L.P. $248 18 payments
  10. Genzyme Corporation $245 6 payments
  11. Other $1,926 93 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,640 304 payments
  2. Consulting Fee $800 1 payment
  3. Education $294 3 payments
Products named General payments · program years 2021–2025
  1. LITFULO $1,090 18 payments
  2. SOTYKTU $830 37 payments
  3. RINVOQ $792 27 payments
  4. Bimzelx $453 32 payments
  5. VTAMA $391 13 payments
  6. OLUMIANT $284 5 payments
  7. DUPIXENT $278 8 payments
  8. CIBINQO $270 17 payments
  9. SKYRIZI $262 11 payments
  10. Winlevi $248 12 payments
  11. Other $3,407 134 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

308 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record